# A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber

> **NCT01804400** · PHASE2 · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 188 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** QAW039
- **DRUG:** Montelukast
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01804400
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01804400

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01804400, "A Clinical Trial to Test How Well Two Drugs, QAW039 and Montelukast Work Both Individually and Together, to Target Allergic Rhinitis Using an Environmental Exposure Chamber". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01804400. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*